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Background and purpose: Acute vestibular symptoms have a profound impact
on patients’ well-being. In this study, health-related quality of life (HRQoL)
and functional impairment were investigated prospectively in patients with dif-
ferent peripheral and central vestibular disorders during the acute symp-
tomatic stage to decipher the most relevant underlying factors.
Methods: In all, 175 patients with acute vestibular disorders were categorized
as central vestibular (CV, n = 40), peripheral vestibular (PV, n = 68) and
episodic vestibular disorders (EV, n = 67). All patients completed scores to
quantify generic HRQoL (European Quality of Life Score Five Dimensions
Five Levels, EQ-5D-5L) and disease-specific HRQoL (Dizziness Handicap
Inventory, DHI). Vestibular-ocular motor signs were assessed by video-oculog-
raphy, vestibular-spinal control by posturography and verticality perception
by measurement of subjective visual vertical.
Results: Patients with PV had a poorer HRQoL compared to patients with
CV and EV (EQ-5D-5L/DHI: PV, 0.53  0.31/56.1  19.7; CV, 0.66  0.28/
43.3  24.0; EV, 0.75  0.24/46.7  21.4). After adjusting for age, gender,
cardiovascular risk factors and non-vestibular brainstem/cerebellar dysfunction
patients with PV persisted to have poorer generic and disease-specific HRQoL
(EQ-5D-5L 0.17, DHI +11.2) than patients with CV. Horizontal sponta-
neous nystagmus was a highly relevant factor for subgroup differences in EQ-
5D-5L and DHI, whilst vertical spontaneous nystagmus, subjective visual ver-
tical and sway path were not. EQ-5D-5L decreased significantly with more
intense horizontal subjective visual vertical in CV (rho = 0.57) and PV
(rho = 0.5) but not EV (rho = 0.13).
Conclusions: Patients with PV have the highest functional impairment of all
patients with acute vestibular disorders. Vestibular-ocular motor disturbance
in the yaw plane has more impact than vestibular-spinal or vestibular-percep-
tive asymmetry in the roll and pitch plane, suggesting that horizontal visual
stability is the most critical for HRQoL.
Introduction
Vertigo and dizziness have profound implications for
health-related quality of life (HRQoL) and function-
ing [1–3]. The most important reasons are restrictions
in mobility, falls and secondary psychological conse-
quences like anxiety, panic disorders or depression
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[4,5]. In chronic vestibular disorders, several factors
were identified, which contribute to symptom severity,
HRQoL and psychological comorbidity [6–8]. Symp-
tom intensity in chronic central and functional
vestibular disorders is higher than in peripheral
vestibular disorders. Subjective symptoms do not cor-
relate with objective tests of semicircular canal (SCC)
or otolith function in the chronic stages of disease [9].
Episodic vestibular syndromes like vestibular migraine
or Meniere’s disease are most frequently associated
with anxiety and depression [4,10], whilst patients with
chronic unilateral or bilateral vestibulopathies do not
have more psychiatric comorbidities than healthy con-
trols [11].
Acute vestibular disorders differ from chronic
vestibulopathies in that central compensation and
behavioural strategies of coping – like physical activity
or cognitive resilience – have less impact on perceived
symptom intensity and impairment. Symptom severity
and HRQoL are probably modulated by different fac-
tors during the acute stage of disease. However, sys-
tematic evaluations, which describe the effects of
disease aetiology, vestibular impairment and patients’
characteristics on symptom intensity, functional
impairment and HRQoL in acute vestibular disorders,
are missing.
Therefore, in the current study, symptom severity,
HRQoL and functioning were investigated prospec-
tively in a large cohort of patients with peripheral and
central vestibular disorders during the acute stage of
symptoms and were correlated to objective measures
of vestibular-ocular motor, vestibular-spinal and
vestibular-perceptive signs, as well as patient-specific
factors (such as age, gender). It is hypothesized that
(i) acute unilateral peripheral vestibulopathies have
the highest symptom intensity and lowest HRQoL, (ii)
ocular motor signs of vestibular asymmetry are the
most important determining factor and (iii) deficits in
the yaw plane have the greatest impact on symptom
severity. The results are important for clinicians to
correctly interpret the patients’ complaints during the
acute stage of vestibular disorders and for future
design of clinical studies in acute vestibulopathies to
define the most relevant functional end-points.
Methods
Patient characteristics and study protocol
In total, 342 consecutive adult patients with acute and
isolated presentations of vertigo/dizziness were
prospectively included in the study at the Emergency
Department of the Ludwig-Maximilian University,
Munich [12]. The following workup was done during
the acute stage of symptoms. (i) A structured medical
history was taken including questions for previous
attacks of vertigo/dizziness, accompanying ear symp-
toms, headaches or central symptoms, and cardiovascu-
lar risk factors. (ii) A standardized neurological and
neuro-otological clinical examination was performed.
(iii) All patients completed scores and scales to quantify
generic and disease-specific HRQoL and functioning
[European Quality of Life Score Five Dimensions Five
Levels (EQ-5D-5L), European Quality of Life Visual
Analogue Scale (EQ-VAS), Dizziness Handicap Inven-
tory (DHI)]. The degree of disability was rated by the
modified Rankin Scale (mRS). (iv) Vestibular-ocular
motor signs were assessed by video-oculography,
vestibular-spinal control by mobile posturography and
verticality perception by measurement of subjective
visual vertical (SVV) using the bucket test method. The
final diagnosis was made following standard diagnostic
guidelines for vestibular disorders (by the Barany Soci-
ety) [13]. A standardized magnetic resonance imaging
(MRI) protocol (whole brain diffusion-weighted imag-
ing, T1-, T2-, T2*-weighted sequences, and time of
flight angiography) was done in 96% of patients to con-
firm or rule out acute central lesions or vestibular
schwannoma. Orthoptic testing was done in 67%, calo-
ric testing in 52%, audiometry in 35%, and vestibular
evoked myogenic potentials in 24% of patients.
In 175 patients a definite neuro-otological diagnosis
according to guideline criteria could be determined.
These patients were categorized into three subgroups for
further analysis: central vestibular disorders (CV)
(vestibular stroke, inflammatory central nervous system
lesions, based on MRI and Video – Head impulse test,
nystagmus, test of skew) (n = 40) [14], peripheral
vestibular disorders (PV) (based on Video – Head
impulse test and caloric testing) (n = 68) and episodic
vestibular disorders (EV) [vestibular migraine (VM)
(n = 26), Meniere’s disease (MD) (n = 20), benign
paroxysmal positional vertigo (BPPV) (n = 21), based
on the respective diagnostic guidelines] (n = 67). A total
of 167 patients did not fulfil the criteria for a definite
neuro-otological diagnosis. The most common reasons
were the following: first attack of vertigo/dizziness (e.g.
suspicious of a beginning MD, VM), transient symptoms
(e.g. suspicious of vestibular transient ischaemic attack,
status post BPPV), mixed presentations (e.g. overlap of
MD/VM), general medical aetiology (e.g. orthostatic
dizziness, metabolic, toxic, infectious disorders). These
patients were excluded from further analysis.
Protocol approval and patient consent
The study was approved by the Ethics Committee of
the University of Munich on 23 February 2015 (57-
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15). The study was conducted according to the Guide-
line for Good Clinical Practice, the Federal Data Pro-
tecting Act and the Helsinki Declaration of the World
Medical Association. All subjects gave their informed,
written consent to participate in the study. The study
was listed in the German Clinical Trial Registry under
the ID DRKS00008992 and the Universal Trial Num-
ber ID U1111-1172-8719.
Data availability
Data reported in this article will be shared with any
appropriately qualified investigator on request.
Scores for HRQoL and symptom intensity
Generic HRQoL and functioning was assessed by the
EQ-5D-5L including subscores for anxiety, pain,
activity, self-care and mobility [overall index score
ranged from negative values to 1 (best health status);
subscores ranged from 1 to 5 (worst impairment)]
[15]. Utility values for the EQ-5D-5L were calculated
using a recently published value set [16]. The overall
subjective estimation of health status was measured
by EQ-VAS [ranging from 0 to 100 (best status)]. Dis-
ease-specific HRQoL and symptom intensity were
quantified using the DHI [ranging from 0 to 100
points (worst symptoms)] [17]. The degree of disability
or dependence was estimated by the mRS (ranging
from 0 to 6 points) with major disability defined as
mRS ≥ 3 [18].
Video-oculographic examination
The following vestibular/ocular motor signs were doc-
umented by video-oculography (EyeSeeCam,
Munich, Germany) during the acute stage of symp-
toms: nystagmus in the straight ahead position (with/
without fixation), horizontal vestibulo-ocular reflex
(VOR) (gain threshold 0.7, compensatory saccades),
gaze holding (lateral/vertical gaze positions), saccades
(horizontal/vertical direction), smooth pursuit (hori-
zontal/vertical direction), horizontal VOR suppres-
sion, skew deviation (cover test in six gaze positions)
[12].
Testing of SVV
The SVV was measured by the bucket test method as
described previously [19]. Ten repetitions (five clock-
wise/five counterclockwise rotations) were performed
and a mean of the deviations was calculated. The nor-
mal range was defined as 0  2.5° [19].
Posturographic assessment
A posturographic measurement of body sway was per-
formed using a mobile device (Wii Balance Board,
Nintendo, Kyoto, Japan). Four conditions were
tested: bipedal standing with eyes open/closed, upright
tandem standing with eyes open/closed. The sway pat-
tern in the medio-lateral (ML) and anterior–posterior
(AP) directions was analysed per condition as normal-
ized sway path (SP) length.
Statistics
For descriptive analysis mean values and standard devi-
ations were calculated for all parameters (e.g. EQ-5D-
5L, EQ-VAS, DHI). For statistical comparison of the
subgroups CV, PV and EV a multivariable linear
regression model with the main outcome EQ-5D-5L
was calculated adjusting for the covariates age, gender,
symptom characteristics (e.g. brainstem/cerebellar dys-
function) (according to [20]) and cardiovascular risk
factors [i.e. diabetes mellitus (DM), hypertension and
atrial fibrillation (A-Fib)] using Stata 14.2 software
(StataCorp LLC, College Station, TX, USA). The sub-
group CV was selected as the reference group. A sensi-
tivity analysis with multivariable linear or logistic
regression models was conducted for secondary out-
come parameters (EQ-VAS, DHI, mRS ≥ 3) adjusting
for the same covariates as in the primary analysis. In an
extended model further quantitative cofactors were
included to analyse their impact for subgroup differ-
ences: (i) spontaneous nystagmus (SPN) without fixa-
tion [in horizontal/vertical direction, expressed as slow
phase velocity (SPV)] (these parameters were taken as
ocular motor equivalents for horizontal and vertical
SCC tone asymmetry); (ii) SP in the ML/AP direction
during stance on firm ground with eyes open, which is
considered as a marker of imbalanced vestibular spinal
tone originating from asymmetric otolith input [21];
(iii) SVV, as a measure of vestibular perception derived
from otolith and vertical SCC inputs (Fig. 1) [22].
Spearman’s rank correlation coefficient was calculated
for outcome parameters (EQ-5D-5L, EQ-VAS, DHI)




Mean age of all 175 patients was 58.6  15.0 years.
Patients with CV were older (64.1  12.2 years) than
patients with PV (55.6  14.6 years) and EV
(58.4  16.1 years) (Table 1). Men were more
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frequently affected in the subgroups with CV (67.5%)
and PV (64.7%), whilst gender was balanced in the
subgroup with EV (men 50.7%). Patients with CV
had more cardiovascular risk factors, namely DM
(10%), hypertension (72.5%) and A-Fib (15%), com-
pared to the patients with PV (DM 2.9%, hyperten-
sion 64.7%, A-Fib 4.4%) and EV (DM 3.5%,
hypertension 65.7%, A-Fib 9.0%) (Table 1).
Figure 1 Quantitative parameters of vestibular tone imbalance in acute vestibular disorders. As a marker of vestibular-ocular motor
asymmetry, spontaneous nystagmus [SPN, horizontal (h) and vertical (v) component] was registered by video-oculography. SPN repre-
sents a tone imbalance derived from the horizontal and vertical semicircular canals (hSCC, vSCC). Vestibular-spinal imbalance was
measured by mobile posturography as the sway path in the medio-lateral (ML) and anterior–posterior (AP) axis. Vestibular-spinal pos-
ture control is thought mainly to rely on otolith inputs. Vestibular perception was quantified by assessment of subjective visual vertical
(SVV), which is integrated from otolith and vertical SCC signs.
© 2020 The Authors. European Journal of Neurology published by John Wiley & Sons Ltd on behalf of European Academy of Neurology
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Generic and disease-specific HRQoL and functional
impairment in acute vestibular disorders
In the entire study cohort, patients’ generic HRQoL was
significantly affected (overall EQ-5D-5L 0.64  0.29).
EQ-5D-5L subscores indicated the highest impairments
for the domains activity (3.0  1.6) and mobility
(2.6  1.3). Judgement of overall health status by EQ-
VAS also showed relevant affection (53.1  21.9). Dis-
ease-specific HRQoL was severely impaired in most
patients (DHI 49.6  21.9). Rating of the degree of dis-
ability indicated a moderate to severe impairment
(mRS ≥ 3) in 69.1% of all patients (Table 2). Subgroup
analysis showed that patients with PV consistently had a
poorer HRQoL (EQ-5D-5L 0.53  0.31; subscore
activity 3.6  1.4, mobility 3.2  1.3) and subjective
health status (EQ-VAS 46.5  22.7) compared to
patients with CV (EQ-5D-5L 0.66  0.28; subscore
activity 2.9  1.7, mobility 2.3  1.2; EQ-VAS
57.2  18.9) and EV (EQ-5D-5L 0.75  0.24; subscore
activity 2.4  1.5, mobility 2.2  1.1; EQ-VAS
57.6  21.4) (Table 2). In EV, patients with VM had
worse HRQoL compared to MD and BPPV (EQ-5D-
5L: VM 0.71  0.23; MD 0.84  0.19; BPPV
0.70  0.28). Disease-specific HRQoL was worse in
patients with PV (DHI 56.1  19.7; mRS ≥ 3 85.3%)
than in patients with CV (DHI 43.3  24.0; mRS ≥ 3
65.0%) and EV [DHI 46.7  21.4 (VM 51.9  22.1;
MD 41.6  21.1; BPPV 45.1  20.4); mRS ≥ 3 55.2%
(VM 66.4%;MD 50.0%; BPPV 47.6%)].
Multivariable linear and logistic regression models in
subgroups of acute vestibular disorders
A comparison of the subgroups CV, PV and EV in
multivariable regression models (adjusted for age, sex,
DM, hypertension, A-Fib and non-vestibular signs of
brainstem/cerebellar dysfunction) showed a statisti-
cally relevant difference between all subgroups for the
variables EQ-5D-5L (F = 12.2, P < 0.0001) (Table 3
(a)) and EQ-VAS (F = 6.0, P = 0.003) (Table 3(b)).
This effect resulted from a significant difference
between the subgroups CV and PV for EQ-5D-5L
(P < 0.01) and EQ-VAS (P = 0.02). Only female gen-
der had a significant effect as a covariable in the
model for EQ-5D-5L (P = 0.01) and EQ-VAS
(P = 0.02). Patients with PV had clinically relevant
lower scores for EQ-5D-5L (b = 0.17) and for EQ-
VAS (b = 10.8) compared to patients with CV.
Multivariable linear and logistic regression models
for DHI and mRS ≥ 3 (adjusted for the above men-
tioned covariables, respectively) indicated an overall
significant difference between subgroups (DHI
F = 4.3, P = 0.02; mRS ≥ 3 v2 = 14.8, P < 0.001).
Again, patients with PV had more severe symptoms
than patients with CV (P = 0.02) (Table 4(a)) and a
higher degree of disability (P < 0.01) (Table 4(b)). In
the regression model for DHI, age (P = 0.003) and
female gender (P = 0.04) were relevant covariables,
and in the model for mRS ≥ 3 female gender
(P = 0.02). Patients with PV had a clinically relevant
Table 1 Patient characteristics in subgroups
Total
group CV PV EV
N (%) 175 (100) 40 (22.9) 68 (38.9) 67 (38.3)
Age in years
(SD)
58.6 (15.0) 64.1 (12.2) 55.6 (14.6) 58.4 (16.1)
Female; N (%) 70 (40.0) 13 (32.5) 24 (35.3) 33 (49.3)
Risk factors (%)
DM 9 (5.1) 4 (10.0) 2 (2.9) 3 (4.5)
Hypertensiona 117 (66.9) 29 (72.5) 44 (64.7) 44 (65.7)
Atrial
fibrillation
15 (8.6) 6 (15.0) 3 (4.4) 6 (9.0)
CV, central vestibular disorders; DM, diabetes mellitus; EV, episodic
vestibular disorders; PV, peripheral vestibular disorders. Patients
with CV were older, more probably of male gender and had more
cardiovascular risk factors. aBlood pressure > 140/90 mmHg.
Table 2 Quality of life and symptom intensity in patient subgroups
Total
group CV PV EV




0.64 (0.29) 0.66 (0.28) 0.53 (0.31) 0.75 (0.24)
Subscore
anxiety
2.0 (1.1) 2.1 (1.2) 1.9 (1.1) 1.9 (1.1)
Subscore pain 2.2 (1.2) 2.3 (1.2) 2.4 (1.3) 2.0 (1.0)
Subscore
activity
3.0 (1.6) 2.9 (1.7) 3.6 (1.4) 2.4 (1.5)
Subscore self-
care
1.8 (1.1) 1.6 (1.1) 2.3 (1.2) 1.5 (0.9)
Subscore
mobility
2.6 (1.3) 2.3 (1.2) 3.2 (1.3) 2.2 (1.1)
EQ-VASb
(SD)
53.1 (21.9) 57.2 (18.9) 46.5 (22.7) 57.6 (21.4)
DHIc (SD) 49.6 (21.9) 43.3 (24.0) 56.1 (19.7) 46.7 (21.4)
mRS ≥ 3 (%) 121 (69.1) 26 (65.0) 58 (85.3) 37 (55.2)
CV, central vestibular disorders; DHI, Dizziness Handicap Inven-
tory; EQ-5D-5L, European Quality of Life Score Five Dimensions
Five Levels; EQ-VAS, European Quality of Life Visual Analogue
Scale; EV, episodic vestibular disorders; HRQoL, health-related
quality of life; mRS, modified Rankin Scale; PV, peripheral vestibu-
lar disorders. Patients with PV had poorer HRQoL and more severe
functional impairment than patients with EV and CV. aOverall index
score ranging from negative values to a maximum of 1 with 1 indi-
cating the best health status; subscores ranging from 1 to 5 with 5
indicating worst impairment bEQ-VAS ranging from 0 to 100 with
100 being the best health status cDHI ranging from 0 to 100 with
100 being the worst impairment due to dizziness.
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higher DHI (b = 11.2) and proportion of mRS ≥ 3
(odds ratio 4.4) compared to patients with CV after
adjusting for the aforementioned variables (Table 4).
Effect of vestibulo-ocular motor, vestibulo-spinal and
vestibulo-perceptive asymmetry on functional
outcome parameters
Patients with PV had a more intense horizontal SPN
(SPV 2.3  3.0°/s) compared to patients with CV (SPV
0.4  0.5°/s, P < 0.001) and EV (SPV 0.3  0.3°/s,
P < 0.001) (ANOVA P < 0.0001). Vertical SPN was only
different for the subgroups PV (SPV 0.6  0.9°/s) ver-
sus EV (SPV 0.3  0.3°/s, P = 0.05), but not CV (SPV
0.4  0.5°/s, P = 0.5) (ANOVA P = 0.05). Mean SVV
deviation was not significantly different in patients with
PV (6.3  5.4°) and patients with CV (5.0  4.8°,
P = 0.37), but higher than in patients with EV
(1.5  1.6°, P < 0.001) (ANOVA P < 0.0001). SP was
comparable in PV (ML 0.47  0.31 m, AP
0.86  0.48 m), CV (ML 0.48  0.29 m, AP
0.76  0.37 m) and EV (ML 0.46  0.31 m, AP
0.73  0.52 m) (ANOVA SP-ML, P = 0.92; ANOVA SP-
AP, P = 0.37). When horizontal SPN, SVV and SP
were included in the multivariable regression models
for EQ-5D-5L, EQ-VAS, DHI and mRS ≥ 3 the fol-
lowing effects were found: SPN was a highly relevant
cofactor for subgroup differences, whilst SVV and SP
Table 3 Multivariable linear regression analysis for outcome param-
eters (a) EQ-5D-5L and (b) EQ-VAS




PV 0.17 (0.29, 0.05) <0.01
EV 0.06 (0.06, 0,19) 0.33
Age 0.0001 (0.003, 0.003) 0.95
Sex
Male Ref
Female 0.11 (0.20, 0.02) 0.01
Diabetes 0.06 (0.25, 0.13) 0.54
Hypertension 0.01 (0.11, 0.08) 0.79








PV 10.8 (20.2, 1.5) 0.02
EV 1.1 (8.5, 10.7) 0.82
Age 0.1 (0.1, 0.3) 0.40
Sex
Male Ref
Female 8.1 (14.7, 1.5) 0.02
Diabetes 12.0 (26.3, 2.4) 0.10
Hypertension 6.6 (13.7, 0.6) 0.07




0.7 (10.0, 8.5) 0.87
CI, confidence interval; CV, central vestibular disorders; EQ-5D-5L,
European Quality of Life Score Five Dimensions Five Levels; EQ-
VAS, European Quality of Life Visual Analogue Scale; EV, episodic
vestibular disorders; PV, peripheral vestibular disorders; Ref, refer-
ence group. Patients with PV had significantly poorer generic
HRQoL compared to CV. Gender was the only significant covari-
able in this model. Partial F-statistic testing the null hypothesis of
no difference between patient subgroups, adjusted for covariables.
Significant values (P < 0.05) in bold.
Table 4 Multivariable linear and logistic regression analysis for out-
come parameters (a) DHI and (b) dichotomized mRS ≥ 3






PV 11.2 (2.0, 20.4) 0.02
EV 2.4 (7.0, 11.9) 0.61
Age 0.4 (0.6, 0.1) 0.003
Sex
Male Ref
Female 7.0 (0.5, 13.5) 0.04
Diabetes 1.3 (12.9, 15.5) 0.85
Hypertension 1.1 (5.9, 8.2) 0.75
Atrial fibrillation 8.8 (20.5, 2.9) 0.14
Brainstem/cerebellar
dysfunction
5.2 (3.9, 14.3) 0.26




PV 4.4 (1.4, 13.2) <0.01
EV 0.8 (0.3, 2.3) 0.71
Age 0.98 (0.96, 1.0) 0.22
Sex
Male Ref
Female 2.5 (1.15, 5.4) 0.02
Diabetes 2.1 (0.38, 11.8) 0.39
Hypertension 1.5 (0.7, 3.4) 0.29
Atrial fibrillation 0.5 (0.2, 1.9) 0.34
Brainstem/cerebellar dysfunction 2.7 (0.9, 8.4) 0.08
CI, confidence interval; CV, central vestibular disorders; DHI, Dizzi-
ness Handicap Inventory; EV, episodic vestibular disorders; mRS,
modified Rankin Scale; OR, odds ratio; PV, peripheral vestibular
disorders; Ref, reference group. Patients with PV had a significantly
higher symptom intensity, lower disease-specific HRQoL and more
severe functional impairment compared to CV. For DHI, age and
gender were significant covariables, for mRS gender. For DHI the
partial F-statistic and for mRS the chi-squared statistic were calcu-
lated, testing the null hypothesis of no difference between patient
subgroups, respectively, adjusted for covariables. Significant values
(P < 0.05) in bold.
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were not. Significant differences between the subgroups
PV and CV disappeared for EQ-5D-5L, DHI and
mRS ≥ 3 when SPN was included in the model.
Correlation analysis of functional outcome parameters
with measures of vestibular asymmetry
Correlation analysis of outcome parameters with vesti-
bulo-ocular motor, vestibulo-spinal and vestibulo-per-
ceptive signs of vestibular asymmetry indicated that
EQ-5D-5L decreased strongly and significantly with
higher SPV of horizontal SPN (rho = 0.57, P < 0.01)
but not vertical SPN (rho = 0.18) in patients with
CV and PV (horizontal SPN, rho = 0.5, P < 0.001;
vertical SPN, rho = 0.18). In patients with EV, nei-
ther horizontal (rho = 0.13) nor vertical SPN
(rho = 0.07) correlated with EQ-5D-5L. DHI
increased moderately with a higher intensity of hori-
zontal SPN in the CV (rho = 0.34, P = 0.04) and the
PV subgroups (rho = 0.41, P < 0.01), but not in the
EV subgroup (rho = 0.07) (Table 5). SP-ML or SP-
AP was not significantly correlated with EQ-5D-5L,
EQ-VAS or DHI for the subgroups CV and PV. In
patients with EV SP-ML and SP-AP correlated moder-
ately and significantly with EQ-5D-5L (rho 0.3/
0.32) and EQ-VAS (rho 0.36/0.31). SVV had a
moderate inverse correlation with EQ-5D-5L
(rho = 0.37, P < 0.01) in patients with PV only.
Discussion
In this prospective study, HRQoL and functional
impairment were systematically investigated in
patients with different types of acute vestibular disor-
ders and analysed against ocular motor, spinal and
perceptive signs of vestibular asymmetry and differen-
tial affection of functional vestibular inputs (from the
SCCs and otoliths). The major findings were the fol-
lowing: (i) patients with PV had a poorer generic and
disease-specific HRQoL, higher symptom intensity
and more severe functional impairment than patients
with CV and EV; (ii) vestibular-ocular motor imbal-
ance (indicated by SPN) had the highest effect on
HRQoL and symptom intensity in patients with PV
and CV; (iii) affection of the horizontal SCC input
had more impact on HRQoL than disturbed vertical
SCC or otolith inputs in PV and CV.
Differential impairment in subtypes of acute vestibular
disorders – clinical relevance
Previous studies showed that physicians tend to clas-
sify vestibular disorders with a subtle symptom inten-
sity and a relatively moderate disability as benign [23].
Our data contradict this view, because patients with
CV (like acute stroke) indeed had on average a lower
symptom intensity of vertigo/dizziness, better HRQoL
and were less severely impaired than patients with PV
(Tables 3 and 4). The difference of 10.8 points in DHI
and 0.17 points in EQ-5D-5L between these sub-
groups and an odds ratio of 4.4 for more severe dis-
ability in mRS in patients with PV has to be
considered as clinically relevant [17,24,25]. Emergency
physicians should be aware that acute CV may be
misdiagnosed if the clinical judgement relies overly on
symptom characteristics like intensity of vertigo/dizzi-
ness or subjectively perceived impairment [26,27].
Modern concepts of symptom-based differentiation of
vestibular disorders are guided more by the presence
of triggers preceding vestibular symptoms, the time
course of symptom onset and evolution, and the pre-
vious history of vestibular attacks [28].
Pathophysiological basis of perceived functional
impairment in acute vestibular disorders
The acute stage of vestibular disorders differs from
the subsequent course in that mechanisms of vestibu-
lar compensation or behavioural adaptation have not
yet fully evolved to ameliorate signs and symptoms of
vestibular asymmetry [29,30]. Consequently, reduced
vestibular input from the sensory organs in the inner
ear (SCCs, otoliths) or altered central projection of
vestibular signals to the eyes, spinal cord or cortex
may translate more directly into perception of symp-
toms or functional impairment in acute vestibular dis-
orders. However, it is unknown to what extent the
disturbance of distinct vestibular domains and net-
works (vestibular-ocular motor, gaze stability; vestibu-
lar-spinal, postural control; vestibular-perceptive,
verticality perception) contributes to functional
impairment and whether the direction of the affected
plane alters perceived symptom intensity and disability
in patients with acute vestibular disorders. Following
the anatomy of the labyrinth, the vestibular system is
organized along the three planes roll, pitch and yaw
[31]. Clinical signs of a vestibular tone imbalance in
the roll plane are a rotatory nystagmus (ocular
motor), a lateral falling tendency (posture) and SVV
tilt (perception) [31]. Static signs and symptoms in the
roll plane originate from asymmetric vestibular inputs
from the vertical SCCs and otoliths [31,32]. Pitch-
plane specific signs may be a vertical nystagmus or an
AP body sway and mostly arise from bilateral affec-
tion of peripheral or central vestibular signal process-
ing [33]. Vestibular tone imbalance in the yaw plane
(asymmetric input from the horizontal SCCs) results
in a horizontal nystagmus (Fig. 1).
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In the current study, SPN was the most relevant
factor for perceived symptom intensity and functional
impairment, whilst postural imbalance and SVV tilt
did not significantly contribute to subgroup differences
in the multivariable regression models of PV and CV.
The horizontal component of SPN was associated
strongly and significantly with lower EQ-5D-5L and
higher DHI scores in PV and CV, whilst the vertical
component of SPN was not (Table 5). These findings
allow three important conclusions.
(i) Impaired gaze stability and oscillopsia are per-
ceived as the most disabling symptoms in patients
with acute PV and CV. Postural control seems to be
less prominently rated. It is reasonable that gaze sta-
bility is weighted as the strongest factor for HRQoL
by patients as it is the prerequisite for stable visual
exploration of the environment and visual guidance of
balance control [34].
(ii) Deficits in the yaw plane contribute more to
functional impairment than in the roll and pitch
plane. Only the horizontal component of SPN was a
significant factor for disability in the regression mod-
els. Signs of vestibular asymmetry in the roll plane
(SVV, SP-ML) and pitch plane (vertical SPN, SP-AP)
were not as significantly associated with symptom
severity and functional impairment. The plane-specific
effect can probably be explained by the fact that the
yaw plane is the dominant plane for natural eye and
head movements in locomotion and spatial orientation
[35]. Freezing of gaze to the horizon is a known beha-
vioural strategy to reduce anxiety in patients with fear
of heights or visual height intolerance [36]. Therefore,
instability of horizontal gaze fixation may cause dis-
comfort and trigger anxiety in patients with acute ver-
tigo/dizziness.
(iii) Deficient vestibular input from the horizontal
SCCs is more disabling than from the vertical SCCs
and the otoliths. This can be derived from a minor
effect of SVV deviation in PV only, which relies on
vertical SCC and otolith signs [22], and a missing
effect of the vertical component of SPN for all sub-
groups, which reflects affection of the vertical SCCs.
Furthermore, SP, which is influenced by otolith sig-
nals to the spinal cord, was not associated signifi-
cantly with functional impairment in PV and CV [21].
The prevalent role of the horizontal SCC could be
explained ontologically, because it is the oldest and
most important for gaze stabilization in different spe-
cies [37,38].
Differences in HRQoL and functioning in acute,
episodic and chronic vestibular disorders
Disease duration seems to play a critical role for the
subjective judgement of functional impairment in dif-
ferent vestibular disorders. Patients with chronic CV
(e.g. after vestibular stroke) have a higher DHI com-
pared to patients with persisting peripheral vestibular
deficits (e.g. long-standing unilateral vestibulopathy,
bilateral vestibulopathy) [9]. Our study shows the
opposite during the acute stage of vestibular symp-
toms (DHI in PV > CV) (Tables 2 and 4). One could
speculate that patients with CV compensate less effec-
tively, if vestibular-cerebellar structures with critical
impact for central plasticity mechanisms are damaged.
It has been shown that patients with midline and cor-
tical cerebellar lesions tend to compensate inade-
quately, whilst patients with Wallenberg’s syndrome
recover similarly compared to patients with acute uni-
lateral peripheral vestibulopathy [29,39]. Another fac-
tor may be that vestibular-ocular motor dysfunction
contributes less to perceived symptoms in the chronic
stage of PV and CV, compared to postural instability
and falls, which are more frequent in patients with




























0.57 0.18 0.0 0.05 0.24 0.50 0.18 0.14 0.15 0.37 0.13 0.07 0.30 0.32 0.18
EQ-VAS 0.06 0.14 0.08 0.08 0.11 0.14 0.09 0.12 0.05 0.03 0.05 0.01 0.36 0.31 0.09
DHI 0.34 0.21 0.08 0.04 0.23 0.41 0.26 0.16 0.06 0.21 0.07 0.14 0.06 0.13 0.16
CV, central vestibular disorders; DHI, Dizziness Handicap Inventory; EQ-5D-5L, European Quality of Life Score Five Dimensions Five
Levels; EQ-VAS, European Quality of Life Visual Analogue Scale; EV, episodic vestibular disorders; PV, peripheral vestibular disorders; SPN
h, horizontal spontaneous nystagmus; SPN v, vertical spontaneous nystagmus, SP-ML, sway path in medio-lateral axis; SP-AP, sway path in
anterior–posterior axis; SVV, subjective visual vertical. In CV and PV – but not EV – the intensity of SPN h significantly correlated with over-
all HRQoL (EQ-5D-5L) and symptom intensity (DHI). SPN v and SVV showed no significant and relevant correlations (correlation coefficient
> 0.3) in either subgroup (except for SVV correlation in the subgroup of PV). SP-ML and SP-AP moderately correlated with EQ-5D-5L and
EQ-VAS in EV. Significant (P < 0.05) and relevant correlations (correlation coefficient > 0.3) are indicated in bold.
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CV [5]. In a previous study, VOR parameters did not
correlate with DHI in chronic PV and CV [9].
Episodic vestibular disorders may have a complex
impact on HRQoL and functioning. The current
study shows (i) a less severe functional impairment in
the acute symptomatic stage for these patients com-
pared to patients with non-episodic PV or CV and (ii)
a poorer HRQoL in patients with VM compared to
MD and BPPV. It could be hypothesized that some
degree of habituation to acute vestibular symptoms
may appear in patients with EV, which is independent
of the degree of objectively measured vestibular dys-
function. Influencing factors could be rather the emo-
tional resilience to deal with symptoms, the coping
strategies and the degree of psychiatric comorbidity
[40,41]. Cultural and socio-economic factors may be
relevant [42]. The potential to adapt to recurrent
vestibular symptoms may furthermore depend on the
underlying vestibular disorder. Patients with VM
develop secondary psychiatric comorbidities like anxi-
ety or depression more often than patients with MD
or recurrent BPPV [4,7,10,40]. In the current study,
the effect of hearing loss on HRQoL was probably
underestimated in MD patients because EQ-5D-5L is
not sensitive to hearing. The Health Utilities Index
Mark 2,3 is more sensitive in this respect [43].
Conclusions
This prospective study establishes a more comprehen-
sive view of the factors relevant for generic and dis-
ease-specific HRQoL and functioning in acute
vestibular disorders. In acute PV and CV, gaze stabil-
ity in the yaw plane plays a key role for perceived
symptom severity and impairment, whilst postural sta-
bility and verticality perception in the roll and pitch
plane are less important. This finding underlines the
importance of a stable horizontal gaze fixation for
suppression of imbalance-related discomfort and anxi-
ety, as well as for postural stability. In EV, perceived
symptom intensity and HRQoL probably depend less
on the impairment of vestibular signal input but
rather on behavioural cofactors (like coping, resilience
or comorbid anxiety). This knowledge is of impor-
tance for the treatment of patients with different
vestibular disorders and for the definition of relevant
patient-related outcome parameters for future inter-
ventional trials in various acute and episodic vestibu-
lar disorders.
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